EyeGate Pharmaceuticals I... (EYEG)
35.30
0.00 (0.01%)
At close: Mar 28, 2025, 3:59 PM
35.48
0.50%
After-hours: Mar 28, 2025, 04:05 PM EDT
EyeGate Pharmaceuticals Income Statement
| Year | FY24 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 16.02M | 12.06K | 2.69M | 1.65M | 407.52K | 669.26K | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | 12.05K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 16.02M | 13.00 | 2.69M | 1.65M | 407.52K | 669.26K | n/a | n/a | n/a | n/a |
| Operating Income | 2.64M | -8.21M | -7.11M | -10.84M | -14.56M | -13.35M | -6.68M | -2.46M | -3.1M | -5.85M |
| Interest Income | 1.25M | 23.34K | 108.07K | 120.36K | 564.00 | 3.68K | 947.00 | 1.1K | 2.19K | 11.13K |
| Pretax Income | 5.66M | -8.08M | -7M | -10.73M | -14.56M | -13.34M | -8.39M | -1.55M | -3.68M | -5.81M |
| Net Income | 7.72M | -8.09M | -7.1M | -10.81M | -13.22M | -13.34M | -8.39M | -1.77M | -3.88M | -6.03M |
| Selling & General & Admin | 5.54M | 4.66M | 4.41M | 4.44M | 4.64M | 5.59M | 3.96M | 1.93M | 2.09M | 2.82M |
| Research & Development | 7.84M | 3.57M | 5.39M | 8.06M | 10.33M | 8.42M | 2.72M | 531.12K | 1.01M | 3.03M |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 13.38M | 8.22M | 9.8M | 12.5M | 14.97M | 14.02M | 6.68M | 2.46M | 3.1M | 5.85M |
| Interest Expense | -21.45K | 4.19K | 325.00 | 1.04K | 1.22K | 275.00 | 1.93M | 441.72K | 611.39K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 13.38M | 8.22M | 9.8M | 12.5M | 14.97M | 14.02M | 6.68M | 2.46M | 3.1M | 5.85M |
| Income Tax | -2.07M | 12.05K | 95.4K | 86.05K | -1.34M | 3.68K | 224.13K | 1.35M | 26.71K | 43.88K |
| Shares Outstanding (Basic) | 3.87M | 3.18M | 3.18M | 2.37M | 950.68K | 588.93K | 462.75K | 462.75K | 334K | 12.86K |
| Shares Outstanding (Diluted) | 4.13M | 3.18M | 3.18M | 2.37M | 950.68K | 588.93K | 462.75K | 462.75K | 334K | 12.86K |
| EPS (Basic) | 1.99 | -2.54 | -2.23 | -4.57 | -13.9 | -22.66 | -18.14 | -3.83 | -11.62 | -469.29 |
| EPS (Diluted) | 1.87 | -2.54 | -2.23 | -4.57 | -13.9 | -22.66 | -18.14 | -3.83 | -11.62 | -469.29 |
| EBITDA | n/a | -8.04M | -6.79M | -10.69M | -14.54M | -13.34M | -6.46M | -1.33M | -3.26M | -6.03M |
| Depreciation & Amortization | n/a | 33.4K | 213.93K | 38.48K | 19.29K | 5.18K | 1.26K | 1.72K | 5.46K | 9.09K |